Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial
Fragile X Syndrome
DOI:
10.1126/scitranslmed.3004214
Publication Date:
2012-09-19T18:16:15Z
AUTHORS (13)
ABSTRACT
Administration of a selective GABA B agonist to individuals with fragile X syndrome improves their deficits in social avoidance, core symptom the disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (232)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....